Nhng t l chuyn i rt thp ch 2 - 10% ALA bn n c th tr thnh EPA v DHA
An in vitro infant model should deliver a barrier with paracellular permeability levels, tight junction and mucus characteristics similar to infants but with the capability to transition overtime to an adult barrier
Inflammopharmacology 7:114 Lovric-Bencic M, Sikiric P, Hanzevacki JS, Seiwerth S, Rogic D, Kusec V, Aralica G, Konjevoda P, Batelja L, Blagaic AB (2004) Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse
Consistency with a bioavailable dose is more effective than occasional high doses
Related Research: BPC-157 Standalone | TB-500 Standalone For laboratory research use only